215 related articles for article (PubMed ID: 18298475)
1. The role of basic fibroblast growth factor in oral submucous fibrosis pathogenesis.
Bishen KA; Radhakrishnan R; Satyamoorthy K
J Oral Pathol Med; 2008 Aug; 37(7):402-11. PubMed ID: 18298475
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of cytokines and growth factors in oral submucous fibrosis.
Haque MF; Harris M; Meghji S; Barrett AW
Cytokine; 1998 Sep; 10(9):713-9. PubMed ID: 9770333
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization.
Utsunomiya H; Tilakaratne WM; Oshiro K; Maruyama S; Suzuki M; Ida-Yonemochi H; Cheng J; Saku T
J Oral Pathol Med; 2005 Sep; 34(8):498-507. PubMed ID: 16091118
[TBL] [Abstract][Full Text] [Related]
4. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
5. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis.
Chiu CJ; Chang ML; Chiang CP; Hahn LJ; Hsieh LL; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):646-53. PubMed ID: 12101112
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of clinicofunctional staging of oral submucous fibrosis with qualitative analysis of collagen fibers under polarizing microscopy.
Ceena DE; Bastian TS; Ashok L; Annigeri RG
Indian J Dent Res; 2009; 20(3):271-6. PubMed ID: 19884707
[TBL] [Abstract][Full Text] [Related]
7. Oral submucous fibrosis: review on aetiology and pathogenesis.
Tilakaratne WM; Klinikowski MF; Saku T; Peters TJ; Warnakulasuriya S
Oral Oncol; 2006 Jul; 42(6):561-8. PubMed ID: 16311067
[TBL] [Abstract][Full Text] [Related]
8. The upregulation of insulin-like growth factor-1 in oral submucous fibrosis.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
Oral Oncol; 2005 Oct; 41(9):940-6. PubMed ID: 16054426
[TBL] [Abstract][Full Text] [Related]
9. Visceral organ involvement is infrequent in oral submucous fibrosis (OSF).
Rajendra R; George B; Sivakaran S; Narendranathan N
Indian J Dent Res; 2001; 12(1):7-20. PubMed ID: 11441804
[TBL] [Abstract][Full Text] [Related]
10. Cell death does not herald epithelial involution ("atrophy") in oral sub mucous fibrosis: a TEM study.
Rajendran R; Sunil ; Twinkle SP; Anikumar TV; Annie J
Indian J Dent Res; 2004; 15(1):13-9. PubMed ID: 15682790
[TBL] [Abstract][Full Text] [Related]
11. [Quantitative and immunohistochemical analysis of endothelin-1 in oral submucous fibrosis].
Xu C; Peng X; Liu S; Fang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Dec; 18(6):394-6, 418. PubMed ID: 12539469
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of NF-kappaB in oral submucous fibrosis--evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts.
Ni WF; Tsai CH; Yang SF; Chang YC
Oral Oncol; 2007 Jul; 43(6):557-62. PubMed ID: 16996785
[TBL] [Abstract][Full Text] [Related]
13. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan.
Shieh DH; Chiang LC; Lee CH; Yang YH; Shieh TY
J Oral Pathol Med; 2004 Oct; 33(9):581-7. PubMed ID: 15357680
[TBL] [Abstract][Full Text] [Related]
14. Oral submucous fibrosis. The South African experience.
VanWyk CW
Indian J Dent Res; 1997; 8(2):39-45. PubMed ID: 9495135
[TBL] [Abstract][Full Text] [Related]
15. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chen YJ; Chang YC
Oral Dis; 2007 Mar; 13(2):234-8. PubMed ID: 17305628
[TBL] [Abstract][Full Text] [Related]
16. Alterations in expression of retinoid receptor beta and p53 in oral submucous fibrosis.
Kaur J; Chakravarti N; Mathur M; Srivastava A; Ralhan R
Oral Dis; 2004 Jul; 10(4):201-6. PubMed ID: 15196140
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-1 expression in oral submucous fibrosis: an immunohistochemical study.
Mishra G; Ranganathan K
Indian J Dent Res; 2010; 21(3):320-5. PubMed ID: 20930336
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis.
Tilakaratne WM; Iqbal Z; Teh MT; Ariyawardana A; Pitiyage G; Cruchley A; Stewart JE; Hagi-Pavli E; Lalli A; Waseem A; Parkinson EK; Fortune F
J Oral Pathol Med; 2008 Jul; 37(6):372-7. PubMed ID: 18221327
[TBL] [Abstract][Full Text] [Related]
19. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.
Auluck A; Rosin MP; Zhang L; Sumanth KN
J Can Dent Assoc; 2008 Oct; 74(8):735-40. PubMed ID: 18845065
[TBL] [Abstract][Full Text] [Related]
20. Multiple logistic regression analysis of risk factors for carcinogenesis of oral submucous fibrosis in mainland China.
Zhou S; Guo F; Li L; Zhou Y; Lei Y; Hu Y; Su H; Chen X; Yin P; Jian X
Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1094-8. PubMed ID: 18684592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
